The Drug Information Handbook for Dentistry is designed for all dental professionals seeking information on commonly prescribed medications, OTCs and herbal products. Written by dentists for dentists, this best-selling resource includes dental-specific content on thousands of drugs, natural products and dietary supplements.
In this handbook, drug monographs are alphabetically organized and cross-referenced by brand and generic name. Each drug monograph includes up to 40 fields of information, with dental-specific content highlighted in red. Fields of interest include:
- Local Anesthetic/Vasoconstrictor Precautions
- Effects on Dental Treatment
- Effects on Bleeding
- Dental Comment
Special sections dedicated to the medically-compromised patient, specific oral conditions and sample prescriptions are included. Lexicomp's Drug Information Handbook for Dentistry is excellent for chair-side use, supporting safe pharmacotherapy and improved patient care.
The # 1 Dental Reference with over 455,000 Copies Sold!
Updates to this Edition
- 43 New Drug Monographs
- Updated Oral Medicine Topics:
- Antiplatelet and Anticoagulation Considerations in Dentistry
- Osteonecrosis of the Jaw
- Systemic Viral Diseases
- Sexually-Transmitted Diseases
- Fungal Infections
- Oral Pain
- Updated Sample Prescriptions:
- Sinus Infection Treatment
- Ulcerative and Erosive Disorders
- Oral Pain
- New Appendix Section:
- Calcium Phosphate Products
- Updated Appendix Information:
- Antigingivitis Dentifrices
Richard L. Wynn, BSPharm, PhD is Professor of Pharmacology at the Baltimore College of Dental Surgery, Dental School, University of Maryland at Baltimore. Dr Wynn has served as a dental educator, researcher, and teacher of dental pharmacology and dental hygiene pharmacology for his entire professional career. He holds a BS (pharmacy; registered pharmacist, Maryland), an MS (physiology) and a PhD (pharmacology) from the University of Maryland. Dr Wynn chaired the Department of Pharmacology at the University of Maryland Dental School from 1980 to 1995. Previously, he chaired the Department of Oral Biology at the University of Kentucky College of Dentistry. He has to his credit over 180 publications including original research articles, textbooks, textbook chapters, monographs, and articles in continuing education journals. He has given over 300 continuing education seminars to dental professionals in the U.S., Canada, and Europe. Dr Wynn has been a consultant to the drug industry for 17 years. His research laboratories have contributed to the development of new analgesics and anesthetics. He is a consultant to the U.S. Pharmacopeia, Dental Drugs and Products section, a consultant to the Academy of General Dentistry, a consultant to the American Dental Association, and a former consultant to the Council on Dental Education, Commission on Accreditation. He is a featured columnist and his drug review articles, entitled Pharmacology Today, appear in each issue of General Dentistry, a journal published by the Academy. He is currently funded by drug industry and government agencies for research on the development of new drugs. One of his primary interests continues to be keeping dental professionals informed on all aspects of drug use in dental practice.
Timothy F. Meiller, DDS, PhD is Professor of Oral Medicine and Diagnostic Sciences at the Baltimore College of Dental Surgery and Professor of Oncology in the Program of Oncology at the Greenebaum Cancer Center, University of Maryland, Baltimore. Dr Meiller has held this position in Oral Medicine at the Dental School for 23 years and serves as an attending faculty at the Greenebaum Cancer Center. He is a Diplomate of the American Board of Oral Medicine. He is a graduate of Johns Hopkins University and the University of Maryland Dental and Graduate Schools, holding a DDS and a PhD in Immunology/Virology. He has over 165 publications to his credit. He maintains an active general dental practice and is a consultant to the National Institutes of Health. He is currently engaged in ongoing investigations into cellular immune dysfunction in oral diseases associated with AIDS, in cancer patients, and in other medically-compromised patients.
Harold L. Crossley, DDS, PhD is Professor Emeritus of Pharmacology at the University of Maryland at Baltimore Dental School. A native of Rhode Island, Dr Crossley received a BS in Pharmacy from the University of Rhode Island in 1964. He later was awarded the MS (1970) and PhD (1972) in the area of Pharmacology. The University of Maryland Dental School in Baltimore awarded Dr Crossley the DDS degree in 1980. He is the Director of Conjoint Sciences and Preclinical Studies at the School of Dentistry and maintains an intramural part-time private dental practice. Dr Crossley has co-authored a number of articles dealing with law enforcement on both a local and Federal level. This liaison with law enforcement agencies keeps him well acquainted with the “drug culture”. He has been appointed to the Governor's Commission on Prescription Drug Abuse and the Maryland State Dental Association's Well-Being Committee. Drawing on this unique background, Dr Crossley has become nationally and internationally recognized as an expert on street drugs and chemical dependency as well as the clinical pharmacology of dental drugs.